Scientific Advisory Board AgreementScientific Advisory Board Agreement • September 15th, 2023 • Acesis Holdings Corp. • Biological products, (no disgnostic substances) • Colorado
Contract Type FiledSeptember 15th, 2023 Company Industry JurisdictionThis Scientific Advisory Board Agreement (the “Agreement”), shall be effective as January 1, 2023 (the “Effective Date”), and is entered into by Acesis Biomed US, Inc., with a business address at 9233 Park Meadows Drive Suite 108, Lone Tree, Colorado 80124, USA (the “Company”), and Dr. Ravi Kacker with a business address at 67 Union St #308, Natick, Massachusetts 01760 (the “Advisor”). This Agreement shall replace and supersede any and all previous written agreements between the Company and Advisor regarding Scientific Advisory Board Services.
Scientific Advisory Board AgreementScientific Advisory Board Agreement • September 15th, 2023 • Acesis Holdings Corp. • Biological products, (no disgnostic substances) • Colorado
Contract Type FiledSeptember 15th, 2023 Company Industry JurisdictionThis Scientific Advisory Board Agreement (the “Agreement”), shall be effective as January 1, 2023 (the “Effective Date”), and is entered into by Acesis Biomed US, Inc., with a business address at 9233 Park Meadows Drive Suite 108, Lone Tree, Colorado 80124, USA (the “Company”), and Dr. Lewis Blumenthal with a business address at 305 Piney Knoll Ln, Hendersonville, NC 28739 (the “Advisor”). This Agreement shall replace and supersede any and all previous written agreements between the Company and Advisor regarding Scientific Advisory Board Services.
Scientific Advisory Board AgreementScientific Advisory Board Agreement • September 15th, 2023 • Acesis Holdings Corp. • Biological products, (no disgnostic substances) • Colorado
Contract Type FiledSeptember 15th, 2023 Company Industry JurisdictionThis Scientific Advisory Board Agreement (the “Agreement”), shall be effective as January 1, 2023 (the “Effective Date”), and is entered into by Acesis Biomed US, Inc., with a business address at 9233 Park Meadows Drive Suite 108, Lone Tree, Colorado 80124, USA (the “Company”), and Dr. Barry Zirkin with a business address at Johns Hopkins Bloomberg School of Public Health (the “Advisor”). This Agreement shall replace and supersede any and all previous written agreements between the Company and Advisor regarding Scientific Advisory Board Services.
Scientific Advisory Board AgreementScientific Advisory Board Agreement • September 15th, 2023 • Acesis Holdings Corp. • Biological products, (no disgnostic substances) • Colorado
Contract Type FiledSeptember 15th, 2023 Company Industry JurisdictionThis Scientific Advisory Board Agreement (the “Agreement”), shall be effective as of January 1, 2023 (the “Effective Date”), and is entered into by Acesis BioMed US, Inc., with a business address at 9233 Park Meadows Drive - Suite 108, Lone Tree, Colorado 80124, USA (the “Company”), and Dr. Vassilios Papadopoulos (the “Advisor”) personally or through VGP Discovery Inc. with a business address at 381 Rosita Lane, Pasadena, CA 91105, USA (the “Advisor”). This Agreement shall replace and supersede any and all previous written agreements between the Company and Advisor regarding Scientific Advisory Board Services.